To Evaluate the Beneficial Effect of Probiotics on NAFLD Patients and the Role of Gut Microbiota Modulation

NCT05402449 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

70

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-Alcoholic Fatty Liver Disease

Interventions

OTHER: Placebo
DIETARY_SUPPLEMENT: Probiotics

Sponsor

GenMont Biotech Incorporation

Collaborators

[object Object]